A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study

Medicine (United States)

Volumn 95, Issue 46, 2016, Pages

  Vaidya, Anand ^a   Cui, Liufu ^b   Sun, Lixia ^c   Lu, Bing ^a   Chen, Shuohua ^b   Liu, Xing ^b   Zhou, Yong ^d   Liu, Xiurong ^b   Xie, Xiaobing ^e   Hu, Frank B ^f   Wu, Shouling ^b   Gao, Xiang ^g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Kailuan Hospital   (China)

^c Hebei Union University Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

China; Cohort study; Diabetes; Fasting glucose; Impaired fasting glucose; Incidence; Obesity

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CHINA; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; ANALYSIS; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; INCIDENCE; PREVALENCE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 85011976075     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005350     Document Type: Article

References (24)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007;356: 213-5.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27: 1047-53.
3. U.S. Department of Health and Human Services, CDC, U.S. Department of Health and Human Services, CDCNational Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. 2011;http://www.cdc.gov/diabetes/pubs/ pdf/ndfs-2011.pdf (accessed Sep 1st, 2015).
4. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-34.
5. Wen CP, Cheng TY, Tsai SP, et al. Increased mortality risks of prediabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005;28: 2756-61.
6. Zheng W, McLerran DF, Rolland B, et al. Association between bodymass index and risk of death in more than 1million Asians. N Engl J Med 2011;364:719-29.
7. Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013;381:1987-2015.
8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
9. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
10. Zhang Q, Zhou Y, Gao X, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-6.
11. Wu S, Huang Z, Yang X, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 2012;5:487-93.
12. Population Census Office under the State Council Tabulation on the 2010 Population Census of People's Republic of China. Beijing:China Statistics Press; 2013.
13. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006.
14. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
15. Shang X, Li J, Tao Q, et al. educational level, obesity and incidence of diabetes among Chinese adult men and women aged 18-59 years old: an 11-year follow-up study. PLoS One 2013;8:e66479.
16. Hu YH, Li GW, Pan XR. [Incidence of NIDDM in Daqing and forecasting of NIDDM in China in 21st century]. Zhonghua Nei Ke Za Zhi 1993;32:173-5.
17. Sun L, Zong G, Pan A, et al. Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr 2013;143:1459-65.
18. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
19. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-59.
20. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(suppl 1):S62-9.
21. Inzucchi SE. Diagnosis of diabetes. N Engl J Med 2013;368:193.
22. Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
23. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491-7.
24. CDC Diabetes Data & Trends. 2013;http://www.cdc.gov/diabetes/statis tics/incidence/fig3.htm. 2013 (Oct 8) (accessed Sep 1st, 2015).